AIP
ACHV icon

Ameritas Investment Partners’s Achieve Life Sciences ACHV Stock Holding History

Ameritas Investment Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,374
Closed -$9.01K – 3199
2025
Q1 		$9.01K Hold
3,374
– – ﹤0.01% 2854
2024
Q4 		$11.9K Hold
3,374
– – ﹤0.01% 2857
2024
Q3 		$16K Hold
3,374
– – ﹤0.01% 2748
2024
Q2 		$15.9K Buy
+3,374
New +$16.3K ﹤0.01% 2718

Other funds holding ACHV

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's ACHV Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Achieve Life Sciences (ACHV) in Q2 2025, closing a stake of 3,374 shares — an estimated $9.01K sold.

Ameritas Investment Partners first reported a position in ACHV in Q2 2024 and held it in 4 quarters. The position peaked at $16K in Q3 2024. 65 funds tracked by Wall St. Rank hold ACHV as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Achieve Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,374 Achieve Life Sciences shares in Q2 2025, an estimated $9.01K.
  • Ameritas Investment Partners first reported a position in Achieve Life Sciences in Q2 2024 and held it in 4 quarters.
  • Ameritas Investment Partners's Achieve Life Sciences position peaked at $16K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.